UBS Group AG Purchases 443,459 Shares of Nano-X Imaging Ltd. $NNOX

UBS Group AG grew its position in Nano-X Imaging Ltd. (NASDAQ:NNOX) by 40.8% in the fourth quarter, HoldingsChannel.com reports. The firm owned 1,530,104 shares of the company’s stock after acquiring an additional 443,459 shares during the period. UBS Group AG’s holdings in Nano-X Imaging were worth $4,284,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. CIBC Bancorp USA Inc. purchased a new position in shares of Nano-X Imaging in the third quarter worth $40,000. BNP Paribas Financial Markets lifted its holdings in shares of Nano-X Imaging by 193.7% in the second quarter. BNP Paribas Financial Markets now owns 11,994 shares of the company’s stock worth $62,000 after buying an additional 7,910 shares in the last quarter. Russell Investments Group Ltd. lifted its holdings in shares of Nano-X Imaging by 62.1% in the third quarter. Russell Investments Group Ltd. now owns 13,787 shares of the company’s stock worth $51,000 after buying an additional 5,283 shares in the last quarter. Tower Research Capital LLC TRC lifted its holdings in shares of Nano-X Imaging by 529.9% in the second quarter. Tower Research Capital LLC TRC now owns 13,794 shares of the company’s stock worth $71,000 after buying an additional 11,604 shares in the last quarter. Finally, PharVision Advisers LLC purchased a new position in shares of Nano-X Imaging in the third quarter worth $56,000. Hedge funds and other institutional investors own 21.49% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the stock. Weiss Ratings reissued a “sell (e+)” rating on shares of Nano-X Imaging in a report on Friday, April 10th. D. Boral Capital reissued a “buy” rating and issued a $5.00 target price on shares of Nano-X Imaging in a report on Monday, April 20th. Cantor Fitzgerald raised shares of Nano-X Imaging to a “strong-buy” rating in a report on Wednesday, March 4th. Finally, Zacks Research downgraded shares of Nano-X Imaging from a “hold” rating to a “strong sell” rating in a report on Wednesday, April 22nd. Three equities research analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating and two have issued a Sell rating to the stock. According to MarketBeat, Nano-X Imaging currently has an average rating of “Moderate Buy” and an average target price of $5.00.

Nano-X Imaging Stock Down 3.7%

Nano-X Imaging stock opened at $1.84 on Friday. The company has a market cap of $128.05 million, a price-to-earnings ratio of -1.16 and a beta of 1.19. The firm’s fifty day moving average is $2.14 and its 200 day moving average is $2.71. Nano-X Imaging Ltd. has a 52-week low of $1.59 and a 52-week high of $5.72.

Nano-X Imaging (NASDAQ:NNOX) last released its quarterly earnings results on Monday, April 20th. The company reported ($0.50) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.15) by ($0.35). The business had revenue of $3.72 million for the quarter, compared to analysts’ expectations of $3.99 million. Nano-X Imaging had a negative net margin of 790.87% and a negative return on equity of 64.65%. During the same period in the previous year, the company earned ($0.21) EPS. On average, equities research analysts anticipate that Nano-X Imaging Ltd. will post -0.65 earnings per share for the current fiscal year.

Nano-X Imaging Company Profile

Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.

The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.